De-risking rejuvenation therapy could be seismic Shift for longevity
Discover more about Shift Bioscience ahead of Daniel Ive's presentation at Master Investor's Investing in the Age of Longevity event.
3 years ago
Latest
Evil Diaries: When smoke gets in your buys
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
3 years ago
Monday Morning Round-up
Mark Watson-Mitchell proves a quick round-up of three previous profile stocks for the start of the week.
3 years ago
Hybridan Small Cap Feast
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
3 years ago
COP26 Week 2 – Turning Point or Failure?
The purpose of COP26 was to formulate initiatives that would decelerate global warming and make the politicians feel good about…
3 years ago
Safestyle UK – a short-term 25% plus gain in sight
Mark Watson-Mitchell takes a look at the prospects of window and door manufacturer Safestyle UK ahead of its trading update.
3 years ago
Hybridan Small Cap Feast
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
3 years ago
Can these 2 FTSE 350 REITs deliver further share price growth?
Robert Stephens, CFA, discusses the prospects for two FTSE 350 real estate investment trusts (REITs)
3 years ago
Evil Diaries: Afghan Woes
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
3 years ago
Hybridan Small Cap Feast
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
3 years ago